Channel Medsystems is developing treatments to meet the unique needs of female patients and the high standards of their healthcare providers. The first application of ChannelMed’s novel cryothermic technology focuses on global endometrial ablation for women with heavy menstrual bleeding. The cryothermic platform at the core of this technology has the potential for multiple future applications. Channel Medsystems is committed to ensuring that women have access to high quality outcomes that can be delivered in the convenience and comfort of their healthcare provider’s office.